Stryker Corporation (LON:0R2S)
357.81
-14.19 (-3.81%)
At close: Oct 31, 2025
Stryker Revenue
Stryker had revenue of $6.06B USD in the quarter ending September 30, 2025, with 10.25% growth. This brings the company's revenue in the last twelve months to $24.38B, up 10.95% year-over-year. In the year 2024, Stryker had annual revenue of $22.60B with 10.23% growth.
Revenue (ttm)
$24.38B
Revenue Growth
+10.95%
P/S Ratio
5.72
Revenue / Employee
$460.02K
Employees
53,000
Market Cap
103.69B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 22.60B | 2.10B | 10.23% |
| Dec 31, 2023 | 20.50B | 2.05B | 11.11% |
| Dec 31, 2022 | 18.45B | 1.34B | 7.84% |
| Dec 31, 2021 | 17.11B | 2.76B | 19.21% |
| Dec 31, 2020 | 14.35B | -533.00M | -3.58% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
Stryker News
- 2 days ago - Decoding Stryker Corp (SYK): A Strategic SWOT Insight - GuruFocus
- 2 days ago - Here's How Much $100 Invested In Stryker 10 Years Ago Would Be Worth Today - Benzinga
- 2 days ago - Compared to Estimates, Stryker (SYK) Q3 Earnings: A Look at Key Metrics - Nasdaq
- 2 days ago - Evercore ISI Maintains Outperform Rating on SYK, Lowers Price Target | SYK Stock News - GuruFocus
- 2 days ago - SYK Stock Falls Despite Q3 Earnings & Sales Beat, '25 View Up - Nasdaq
- 2 days ago - BTIG Maintains 'Buy' Rating for Stryker (SYK) and Raises Price Target | SYK Stock News - GuruFocus
- 3 days ago - Stryker Corp (SYK) Q3 2025 Earnings Call Highlights: Strong Organic Growth and Strategic ... - GuruFocus
- 3 days ago - Q3 2025 Stryker Corp Earnings Call Transcript - GuruFocus